Combined Synopsis/SolicitationActiveHT941026Q2067
Pharmacy fingertip Testing at 374 MDSS at Yokota Air Base Japan
DEPT OF DEFENSE / DEFENSE HEALTH AGENCY (DHA) / DEFENSE HEALTH AGENCY HCD WESTKey dates?
- Posted?
- Aug 25, 2026
- Response deadline?
- Aug 26, 2026, 6:00 PM UTC
- Archive date?
- Sep 10, 2026
- Archive type?
- auto15
Classification?
- Notice type?
- Combined Synopsis/Solicitation
- Base type?
- Combined Synopsis/Solicitation
- Set-aside?
- No Set aside used
- Set-aside code?
- NONE
- PSC?
- Q301
NAICS?
Issuing office?
- Department?
- DEPT OF DEFENSE
- Sub-tier?
- DEFENSE HEALTH AGENCY (DHA)
- Office?
- DEFENSE HEALTH AGENCY HCD WEST
- Office code?
- 097.97DH.HT9410
- Organization type?
- OFFICE
- Office address?
- CAMP PENDLETON, CA, 92055, USA
Place of performance?
- Street?
- —
- Street 2?
- —
- City?
- YOKOTA
- State?
- —
- Zip?
- —
- Country?
- JAPAN
Contacts?
- Raphael Badagborprimary
- Marcela Cervantessecondary
Description?
NOTICE TO CONTRACTOR This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Federal Acquisition Regulation (FAR) Part 12. This announcement constitutes the solicitation. Offers are being requested, and a separate written solicitation will not be issued. Solicitation number HT941026Q2067 is issued as a Request for Quote (RFQ). Defense Health Agency Contracting Activity (DHACA) Healthcare Contracting Division-West (HCD-W) requests responses from qualified sources capable of providing the following: Pharmacy fingertip testing at 374 MDSS at Yokota Air Base Japan This is an unrestricted procurement, inviting full and open competition. This solicitation incorporates provisions and clauses by reference. The full text of provisions and clauses may be accessed electronically at www.acquisition.gov. This requirement is for non-personal services Pharmacy fingertip testing service to comply with TJC and USP 797 standards regarding sterile intravenous IV compounding requirements for 374th Medical Group, Yokota Airbase, Japan IAW the PWS. Period of Performance: Base plus 4 option Years See Combined Synopsis HT941026Q2067 (Rev 1 dated 8-19-2026 extended quotes due date pending answers/clarification) and attachments (PWS, Attachment 2 and 3) for further details Added attachment for Q&A. Extend quotes due date to 26-Aug-2026
Attachments (5)?
- Download📎 Q+and+A+HT941026Q2067.pdfapplication/pdf · 95 KB
- Download📎 Attachment+3+-+Quote+Sheet.xlsxapplication/octet-stream · 23 KB
- Download📎 PWS+-+FY27+Pharmacy+Services+%28updated+8+Jul+26%29.pdfapplication/pdf · 227 KB
- Download📎 CSS+HT941026Q2067+Rev.1+%288-19-2026%29.pdfapplication/pdf · 400 KB
- Download📎 Attachment+2+-+Past+Performance+Questionnaire.docxapplication/octet-stream · 33 KB
Other notices in this solicitation?
Similar open contracts
Metadata?
- Notice ID?
- e2154c0d59d9490787e3119808c6320f
- Full path?
- DEPT OF DEFENSE.DEFENSE HEALTH AGENCY (DHA).DEFENSE HEALTH AGENCY HCD WEST
- Office code?
- 097.97DH.HT9410
- Ingested?
- Aug 25, 2026
- Updated?
- Aug 26, 2026